Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:32 PM
Ignite Modification Date:
2025-12-24 @ 4:32 PM
NCT ID:
NCT05175066
Eligibility Criteria:
Inclusion Criteria:
patients that was diagnosed with non-metastatic breast cancer and anthracycline-based chemotherapy were planned for them
Exclusion Criteria:
* Established ischemic heart disease
* Baseline LVEF \<50%, cardiomyopathy (restrictive, dilated or hypertrophic) detected by transthoracic echocardiography
* Moderate or severe valvular disease,
* Prior chemotherapy,
* Presence of contraindication for beta-blockers and cardiac arrhythmias and lack of patient compliance
* Patients that had consuming angiotensin converting enzyme Inhibitors, angiotensin receptor Inhibitors,diuretics,statins,other beta-blockers or non-dihydropyridin calcium channel blockers
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
35 Years
Maximum Age:
65 Years
Study:
NCT05175066
Study Brief:
Protocol Section:
NCT05175066